Chimeric Antigen Receptor (CAR)

Chimeric Antigen Receptors (CARs) are engineered proteins used in cancer treatment. They are designed to redirect a patient’s own immune cells, specifically T cells, to identify and attack cancer cells. Scientists take T cells from the patient, modify them in the lab to express CARs that recognize specific proteins on cancer cells, and then infuse these modified cells back into the patient. This process enhances the immune system's ability to detect and destroy tumors, making CAR therapy a promising approach in battling certain types of cancers, particularly blood cancers like leukemia and lymphoma.